DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC)

Historical Holders from Q4 2018 to Q4 2025

Type / Class
Equity / Voting Common Shares, no par value
Symbol
DMAC on Nasdaq
Shares outstanding
51,654,406
Price per share
$7.96
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
12,754,591
Holdings value
$82,807,935
% of all portfolios
0%
Share change
+4,001,424
Value change
+$25,371,624
Average buys %
+0%
Average sells %
-0%
Number of holders
77
Price from insider filings
$8.42
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
TomEnterprise AB 16% $30,935,399 8,383,577 TomEnterprise AB 23 Jul 2025
TRILL AB 15% +14% $45,577,410 +$5,870,000 7,764,465 +15% Trill AB 14 Aug 2025
JACINTO RICHARD II 9.6% $34,067,114 4,958,823 Richard Jacinto II 30 Sep 2025
COOPERMAN LEON G 6.3% +5% $22,471,432 +$1,096,446 3,269,761 +5.1% Cooperman Leon G. 30 Sep 2025
As of 30 Sep 2025, DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) has 77 institutional shareholders filing 13F forms. They hold 12,754,591 shares of 51,654,406 outstanding shares (25%) .

Top 25 institutional shareholders own 23% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
COOPERMAN LEON G 6.3% 3,269,761 +98% 0.55% $17,644,158
BlackRock, Inc. 3.2% 1,678,139 +41% 0% $11,528,816
MILLENNIUM MANAGEMENT LLC 2.3% 1,187,309 0.01% $8,156,813
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 1.7% 875,000 +35% 11% $6,011,250
GEODE CAPITAL MANAGEMENT, LLC 1.4% 711,818 +13% 0% $4,891,114
VANGUARD GROUP INC 1.3% 664,575 -57% 0% $4,565,630
MORGAN STANLEY 1.1% 579,585 +141% 0% $3,981,749
FIRST MANHATTAN CO. LLC. 0.98% 505,000 -17% 0.01% $3,469,350
STATE STREET CORP 0.92% 476,583 +89% 0% $3,274,125
Bleichroeder LP 0.74% 382,317 0% 0.51% $2,626,518
NORTHERN TRUST CORP 0.66% 339,578 +4.6% 0% $2,332,901
LPL Financial LLC 0.39% 203,150 +2.9% 0% $1,395,641
OSAIC HOLDINGS, INC. 0.35% 182,305 +26% 0% $1,253,699
Corient Private Wealth LLC 0.27% 140,000 0% $961,800
Corient IA LLC 0.26% 132,500 0.68% $910,275
CANTOR FITZGERALD, L. P. 0.19% 100,000 0.01% $687,000
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.18% 92,427 +16% 0% $634,973
GOLDMAN SACHS GROUP INC 0.15% 77,292 +332% 0% $530,996
Nuveen, LLC 0.14% 74,667 +117% 0% $512,962
CITADEL ADVISORS LLC 0.13% 69,352 0% $476,448
Blue Trust, Inc. 0.13% 69,122 0% 0.01% $474,868
Bank of New York Mellon Corp 0.13% 68,941 +15% 0% $473,621
JANE STREET GROUP, LLC 0.11% 57,546 0% $395,341
Meridian Wealth Management, LLC 0.1% 51,666 +89% 0.01% $354,945
Private Capital Management, LLC 0.1% 50,000 0.03% $343,500

Institutional Holders of DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 4,926 $39,211 $7.96 2
2025 Q3 12,754,591 $82,807,935 +$25,371,624 $6.87 77
2025 Q2 8,764,697 $34,183,334 +$4,951,603 $3.90 58
2025 Q1 7,514,092 $28,477,666 +$2,854,600 $3.79 57
2024 Q4 6,729,012 $36,539,618 +$6,248,431 $5.43 45
2024 Q3 5,580,411 $23,326,555 +$2,250,137 $4.19 40
2024 Q2 5,062,392 $14,934,296 +$1,369,211 $2.95 32
2024 Q1 4,598,019 $12,730,274 +$2,182,675 $2.77 31
2023 Q4 3,805,489 $10,807,735 -$704,236 $2.84 33
2023 Q3 4,214,598 $10,874,575 +$1,922,273 $2.58 32
2023 Q2 3,489,804 $15,077,283 +$4,150,479 $4.32 28
2023 Q1 2,565,155 $3,924,523 +$61,557 $1.53 21
2022 Q4 2,468,709 $3,901,946 -$10,002 $1.58 25
2022 Q3 2,526,874 $3,131,750 -$2,355,213 $1.24 22
2022 Q2 3,668,192 $7,410,266 -$803,921 $2.02 23
2022 Q1 4,004,315 $10,012,947 -$403,207 $2.50 25
2021 Q4 3,993,068 $14,891,000 +$4,429,302 $3.73 33
2021 Q3 2,804,515 $11,249,000 -$3,546,474 $4.01 31
2021 Q2 3,783,875 $16,902,000 -$12,627,816 $4.45 37
2021 Q1 5,687,548 $88,057,000 +$32,608,757 $9.15 36
2020 Q4 5,197,423 $52,632,000 -$3,663,646 $10.14 31
2020 Q3 6,699,021 $28,349,600 +$15,565,685 $4.24 28
2020 Q2 0 $0 -$333,998 0
2020 Q1 2,923,081 $8,225,000 +$5,984,181 $2.80 17
2019 Q4 800,511 $3,883,000 -$428,552 $4.85 10
2019 Q3 954,612 $1,971,000 -$925,170 $2.06 12
2019 Q2 1,282,678 $6,362,000 +$2,583,585 $4.96 12
2019 Q1 310 $1,000 -$659,990 $3.23 1
2018 Q4 1,032,059 $3,002,000 +$3,002,007 $2.91 6